Across the U.S., migraines are affecting 39 million men, women, and children reports the Migraine Research Foundation. According to a recent study by Migraine Buddy and Healint, 30% of people who suffer from migraines have tried cannabis to relieve their symptoms.
Migraine Buddy, an app that allows users to track data about their migraines to share with their physicians, collected data from nearly 10,000 sufferers in the U.S. and Canada. Participants in the study consumed cannabis in a variety of ways such as smoking, vaping, tinctures, oils and edibles.
About eight in 10, or 82%, say they have found relief from their consumption of cannabis.
“Cannabis is becoming a prominent treatment option for chronic pain patients, especially for migraineurs,” Healint CEO, Francois Cadiou, said in a press release.
“With more and more states across the United States legalizing medical marijuana, migraine patients are becoming acquainted with cannabis as a natural remedy that can help alleviate migraines and even prevent them. Research about the benefits of cannabis use among migraine patients is slowly emerging, but more must be done to properly inform individuals about the use and dosage of medical marijuana to treat migraines.”
Emergency Medicine physician, Dr. Andrew Rizzo, further noted the importance of these studies in allowing patients proper treatment.
“As more research is conducted on the effects of cannabis on headache and migraine, cannabis is proving to be an effective medication that can help migraineurs better manage their condition,” he stated.
While the emerging research is promising, he continued, “we urgently need more studies to be conducted on the proper administration method and dosage to better inform our patients.”
Research into the effectiveness of cannabis for migraine pain is still on the up and up. However, this study is further backed by a few others.
In 2016, another study, this one published in Pharmacotherapy, found that 40% of patients who were recommended cannabis as treatment for migraines experienced a decrease in frequency from 10.4 migraines per month, to 4.6. As cannabis use continues to grow, and state governments are increasingly seeing green, hopes are high for further research into cannabis’ effectiveness on a variety of ailments.